Selected Publications

Haubrich, B.A., Nayyab, S., Gallati, M., Hernandez, J, Williams,C., Whitman, A., Zimmerman, T., Li, Q., Chen, Y., Zhou, C.-Z., Basu, A., Reid, C.W. Inhibition of Streptococcus pneumoniae by masarimycin. Microbiology. 2022; 168(4), doi: 10.1099/mic.0.001182.

Gallati, M., Point, B., Reid, C. W. Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth. J. Vis. Exp, 2022; (179), e63191, doi:10.3791/63191

Roohani K, Haubrich BA, Yue KL, D'Souza N, Montalbano A, Rynearson T, Menden-Deuer S, Reid CW. Trophic upgrading and mobilization of wax esters in microzooplankton. PeerJ. 2019;7:e7549. doi: 10.7717/peerj.7549. eCollection 2019. PubMed PMID: 31489268; PubMed Central PMCID: PMC6705382.

Smith AM, Papaleo C, Reid CW, Bliss JM. RNA-Seq reveals a central role for lectin, C1q and von Willebrand factor A domains in the defensive glue of a terrestrial slug. Biofouling. 2017 Oct;33(9):741-754. doi: 10.1080/08927014.2017.1361413. Epub 2017 Sep 13. PubMed PMID: 28899232; PubMed Central PMCID: PMC6124484.

Nayyab S, O'Connor M, Brewster J, Gravier J, Jamieson M, Magno E, Miller RD, Phelan D, Roohani K, Williard P, Basu A, Reid CW. Diamide Inhibitors of the Bacillus subtilis N-Acetylglucosaminidase LytG That Exhibit Antibacterial Activity. ACS Infect Dis. 2017 Jun 9;3(6):421-427. doi: 10.1021/acsinfecdis.7b00005. Epub 2017 May 8. PubMed PMID: 28448118; PubMed Central PMCID: PMC5789777.

Ménard R, Schoenhofen IC, Tao L, Aubry A, Bouchard P, Reid CW, Lachance P, Twine SM, Fulton KM, Cui Q, Hogues H, Purisima EO, Sulea T, Logan SM. Small-molecule inhibitors of the pseudaminic acid biosynthetic pathway: targeting motility as a key bacterial virulence factor. Antimicrob Agents Chemother. 2014 Dec;58(12):7430-40. doi: 10.1128/AAC.03858-14. Epub 2014 Sep 29. PubMed PMID: 25267679; PubMed Central PMCID: PMC4249573.

Kuhn, H., Gutelius, D., Black, E., Nadolny, C., Basu, A., Reid, C. (2014) 
Anti-bacterial glycosyl triazoles – identification of an N-acetylglucosamine derivative with bacteriostatic activity against Bacillus. Med Chem Comm, Advance Article, doi:10.1039/C4MD00127C

Gutelius, D., Hokeness, K., Logan, S.M., Reid, C.W. (2014) Functional analysis of SleC from Clostridium difficile, Microbiology, 160, 209-216.

Hokeness, K., Lux, H., Kratch, J., Nadolny, C., Aicardi, K., Reid, C.W. (2014) The effects of fungal volatile organic compounds on bone marrow stromal cells, Can J Microbiol,60, 1-4.

Reid, C.W., and Gutelius, D. (2012) Opportunites in bacterial cell wall biogenesis. J Glycomics Lipidomics, 2:e110. doi:10.4172/2153-0637.1000e110.

Reid, C.W., Vinogradov, E., Li, J., Jarrell, H.C., Logan, S.M., Brisson, J.-R. (2012) Structural characterization of surface glycans from Clostridium difficile. Carbohyd Res. 354, 65-73. PMID : 22560631.

Reid, C.W.; Fulton, K.M.; Twine, S.M. (2010) Never take candy from a stranger: pathogen trickery and the glycome. Future Microbiol.5,267-288.PMID:20143949.

Book Chapters:

1)      Reid, C.W. (2012) Methods for the analysis of microbial lipid-linked oligosaccharides by mass spectrometry. In C.W. Reid, S.M. Twine, and A.N. Reid (eds), Bacterial Glycomics: Current research, technology, and applications. Horizon Scientific Press, London, UK. 179-191

2) Reid, C.W.; Stupak, J.; and Szymanski, C. (2010) Characterization of lipid-linked oligosaccharides by mass spectrometry. In J. Li (eds.), Methods in Functional Glycomics. 187-198, Humana Press, USA.
3)     McNally, D.J., Reid, C.W., Brisson, J.-R., and Soo, E. 2007. Campylobacter metabolomics. In I. Nachamkin, C.M. Szymanski, and M. Blaser (eds.), Campylobacter, 3rd ed. ASM Press,     Washington, D.C. 523-542.

Edited Books

1) C.W. Reid, S.M. Twine, and A.N. Reid (eds), Bacterial Glycomics: Current research, technology, and applications. (2012) Horizon Scientific Press, London, UK. 

Patents

1) Clostridium difficile lipoteichoic acid and uses thereof. USSN 61/561,290

2.  Diamide antimicrobial agents. Patent filing number: 62878561.

3. Novel antibacterial compounds and methods of making and using same.  US-Patent (2017) Attorney docket number: 365565.00019(P1)